# Eloxx Pharmaceuticals, Inc.: Form 8-K, filed Sep 7, 2023

- Company: [Eloxx Pharmaceuticals, Inc.](/companies/elox.md) (CIK 1035354)
- Form: 8-K
- Filed: 2023-09-07
- Accepted by EDGAR: Sep 7, 2023, 10:14 ET
- Period: 2023-09-07
- Accession: 0001104659-23-098843
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1035354/000110465923098843/tm2325683d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1035354/000110465923098843/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1035354/000110465923098843/tm2325683d1_8k.htm

Filed Sep 7, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-098843. Last ingested by Listed: Nov 15, 2026, 04:18 ET. No prices; not investment advice.
